Clinical Trial Update: Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating escitalopram, a serotonin transporter inhibitor, for pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED